Industry Data and Market Intelligence

In a rapidly evolving healthcare environment, the MedTech industry cannot compete, invest or advocate effectively without credible, current and actionable data.

Market access is tightening. Funding decisions are increasingly evidence-driven. Procurement frameworks are shifting. Policy reform continues to reshape reimbursement and regulatory pathways. In this context, data is no longer a “nice to have” — it is a strategic asset.

At SAMED, this strategic imperative is led by our Industry Data Committee.

Driving Evidence-Based Decision-Making

The Industry Data Committee exists to equip members with the intelligence required to make informed commercial, investment and policy decisions. Through structured data initiatives, the Committee produces:

  • Annual market reports
  • Quarterly industry data analyses
  • Market size and segmentation insights
  • Access and reimbursement trend analysis
  • Benchmarking and performance indicators

These insights enable members to:

  • Inform long-term investment and localisation decisions
  • Support policy submissions with credible evidence
  • Benchmark performance against industry trends
  • Strengthen market access strategies
  • Identify growth opportunities

Expanding Access to Data — Together

Recognising that high-quality data often comes at a significant cost, SAMED works proactively with industry partners to negotiate preferential pricing for members.

Through collective engagement and scale, we secure improved access to critical datasets — ensuring members are empowered with the intelligence they need, at commercially viable rates.

This collaborative approach strengthens the entire sector by:

  • Reducing duplication of cost
  • Increasing data accessibility
  • Enhancing strategic capability across companies of all sizes
View Offerings

Supporting Sustainable Sector Growth

By combining rigorous analysis with strategic partnerships, the Industry Data Committee ensures that South Africa’s MedTech sector is guided by facts, not assumptions.

Data strengthens advocacy.
Data sharpens strategy.
Data supports sustainable growth.

We invite members to engage with the Industry Data Committee and leverage these insights to drive informed, future-focused decision-making across the MedTech value chain.